Advertisement

Topics

Sucampo Pharmaceuticals, Inc. & Abbott Company Profile

16:37 EDT 24th June 2018 | BioPortfolio

About the AMITIZA Development Program in Japan


News Articles [685 Associated News Articles listed on BioPortfolio]

Mallinckrodt to buy Sucampo Pharmaceuticals

Specialty pharmaceuticals manufacturer Mallinckrodt has agreed to buy biopharmaceuticals producer Sucampo, including its commercial and development assets.  The transaction is subject to customar...

Mallinckrodt to acquire Sucampo Pharmaceuticals

Mallinckrodt and Sucampo Pharmaceuticals announced an agreement in which Mallinckrodt will acquire Sucampo for approximately $1.2 billion.The transaction was approved by the boards of directors of bot...

Mallinckrodt snaps up Sucampo for $1.2bn

UK-based pharma Mallinckrodt is buying US biopharma Sucampo Pharmaceuticals for around $1.2 billion.

Mallinckrodt agrees to buy Sucampo Pharma for $1.2bn

Mallinckrodt has signed an agreement to purchase all outstanding shares of Sucampo Pharmaceuticals for around $1.2bn. Under the agreement, Mallinckrodt...Read More... The post Mallinckrodt agrees to b...

Mallinckrodt buys Sucampo

Mallinckrodt PLC agreed to pay $18 per share (an 8% premium) to acquire Sucampo Pharmaceuticals Inc., a public firm developing treatments for GI conditions and rare diseases. Including debt, the enter...

Troubled Mallinckrodt pays $1.2bn for Sucampo

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer to...

Sucampo Pharmaceuticals (SCMP) Downgraded by Zacks Investment Research

According to Zacks, "Sucampo's pending acquisition by Mallinckrodt for $1.2 billion have raised investor concerns that the latter may be underpaying for the company. A sNDA for label expansion of ...

Sucampo Pharmaceuticals (SCMP) Downgraded by Zacks Investment Research to Hold

According to Zacks, "Sucampo's pending acquisition by Mallinckrodt for $1.2 billion have raised investor concerns that the latter may be underpaying for the company. A sNDA for label expansion of ...

Drugs and Medications [292 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Abbott Welding Supply]

Oxygen Compressed Label

Androgel [Abbott Products, Inc.]

These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%.AndroGel (testosterone gel) 1.62% for topic...

Aceon [Abbott Products, Inc.]

These highlights do not include all the information needed to use ACEON safely and effectively. See full prescribing information for ACEON.ACEON (perindopril erbumine) 2, 4 and 8 mg Tablets Initial U....

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Zemplar [Abbott Laboratories]

These highlights do not include all the information needed to use ZEMPLAR safely and effectively. See full prescribing information for ZEMPLAR.ZEMPLAR (paricalcitol) capsules Initial U.S. Approval: 19...

PubMed Articles [157 Associated PubMed Articles listed on BioPortfolio]

Use of the Novel Surgical Enhancement Tools for Less Invasive Abbott HeartMate 3™ Implantation.

We present our initial experience with the novel Abbott surgical enhancement tools for less invasive HeartMate 3TM Left Ventricular Assist System (LVAS) implantation (Abbott, Chicago, IL, USA). Three ...

Differences of Cd uptake and expression of OAS and IRT genes in two varieties of ryegrasses.

Pot experiment was conducted to study the difference of cadmium uptake and OAS and IRT genes' expression between the two ryegrass varieties under cadmium stress. The results showed that with the incre...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam.

Viral load (VL) monitoring of HIV-infected patients in decentralized areas is limited due to logistic constraints. Dried Blood Spots (DBS) offer the opportunity to collect samples in remote area which...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Clinical Trials [299 Associated Clinical Trials listed on BioPortfolio]

ABSORB II Randomized Controlled Trial

Prospective, randomized (2:1), active control, single blinded, parallel two-arm, multi-center clinical investigation using Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular ...

Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems

The purpose of the study is to evaluate the safety and effectiveness of the Abbott Sensor Based Glucose Monitoring System Personal (System-P) and Abbott Sensor Based Glucose Monitoring Sys...

Cefdinir Capsules 300 mg, Non-fasting

This study will compare the relative bioavailability (rate and extent of absorption) of 300 mg Cefdinir Capsules manufactured and distributed by TEVA pharmaceuticals USA with that of OMNIC...

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

The objective of this study is to compare the relative bioavailability of cefdinir for oral suspension 250 mg/5mL (manufactured and distributed by TEVA Pharmaceuticals USA) with that of OM...

Paediatric Use of the Abbott Sensor Based Glucose Monitoring System

Accuracy evaluation of the Abbott Sensor Based Glucose Monitoring System when used by children with diabetes.

Companies [1358 Associated Companies listed on BioPortfolio]

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on proston...

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary d...

Sucampo Pharmaceuticals, Inc. & Abbott

About the AMITIZA Development Program in Japan

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...

More Information about "Sucampo Pharmaceuticals, Inc. & Abbott" on BioPortfolio

We have published hundreds of Sucampo Pharmaceuticals, Inc. & Abbott news stories on BioPortfolio along with dozens of Sucampo Pharmaceuticals, Inc. & Abbott Clinical Trials and PubMed Articles about Sucampo Pharmaceuticals, Inc. & Abbott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sucampo Pharmaceuticals, Inc. & Abbott Companies in our database. You can also find out about relevant Sucampo Pharmaceuticals, Inc. & Abbott Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record